The topic of this article may not meet Wikipedia's
notability guidelines for companies and organizations. (January 2021) |
Penumbra, Inc. is a medical device company [1] [2] headquartered in Alameda, California. [3] [4] The company was founded by Arani Bose and Adam Elsesser in 2004. [5] It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. [6]
Penumbra manufactures several medical devices but specializes in the neuro/vascular market and creates devices that help treat aneurysms and ischemic stroke. [7] [8]
In 2014, Penumbra launched its Apollo system, a device that “enables minimally invasive removal of deeply seated tissue and fluids in the brain,” allowing for otherwise inoperable blood clots to be removed. [9] [10]
In 2015 the company issued an IPO on the NYSE. [11] In 2018 the company acquired 40% of the outstanding shares of virtual reality joint venture MVI Health. [12] In 2017 the company acquired the Italian distributor Crossmed. [13]
Criticism of Penumbra has followed various aspects of its products and business practices. In 2016 a lawsuit claimed the Penumbra Coil 400 caused brain damage after surgery. [14] The company's specialized catheter has been linked to the deaths of stroke patients, and it was a target of stock short sellers in 2020. [15] [16] [17][ excessive citations] According to the Foundation for Financial Journalism, this is a significant dilemma. [18]
A request has been sent to The SEC and U.S. Food and Drug Administration to launch an investigation. [19] A scientist who has published research articles showing the reliability of Penumbra's medical products is (allegedly) an internet fabrication. [20]
In 2011 the company recalled its Penumbra Coil 400. [21] In 2017 the company recalled a 3D revascularization device. [22] In 2020 the company recalled one of its catheter used during heart surgery due to increased risk of mortality and serious injury. [23] [24] [25][ excessive citations]
The topic of this article may not meet Wikipedia's
notability guidelines for companies and organizations. (January 2021) |
Penumbra, Inc. is a medical device company [1] [2] headquartered in Alameda, California. [3] [4] The company was founded by Arani Bose and Adam Elsesser in 2004. [5] It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. [6]
Penumbra manufactures several medical devices but specializes in the neuro/vascular market and creates devices that help treat aneurysms and ischemic stroke. [7] [8]
In 2014, Penumbra launched its Apollo system, a device that “enables minimally invasive removal of deeply seated tissue and fluids in the brain,” allowing for otherwise inoperable blood clots to be removed. [9] [10]
In 2015 the company issued an IPO on the NYSE. [11] In 2018 the company acquired 40% of the outstanding shares of virtual reality joint venture MVI Health. [12] In 2017 the company acquired the Italian distributor Crossmed. [13]
Criticism of Penumbra has followed various aspects of its products and business practices. In 2016 a lawsuit claimed the Penumbra Coil 400 caused brain damage after surgery. [14] The company's specialized catheter has been linked to the deaths of stroke patients, and it was a target of stock short sellers in 2020. [15] [16] [17][ excessive citations] According to the Foundation for Financial Journalism, this is a significant dilemma. [18]
A request has been sent to The SEC and U.S. Food and Drug Administration to launch an investigation. [19] A scientist who has published research articles showing the reliability of Penumbra's medical products is (allegedly) an internet fabrication. [20]
In 2011 the company recalled its Penumbra Coil 400. [21] In 2017 the company recalled a 3D revascularization device. [22] In 2020 the company recalled one of its catheter used during heart surgery due to increased risk of mortality and serious injury. [23] [24] [25][ excessive citations]